Celldex Therapeutics (United States)

02494 (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

Sep 18 - Mar 22

Augmentation of CD38 Tumour-Targeting with immunostimulation

MRC award to University of Southampton

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}